KAIROS PHARMA LTD
Q4 2024 13F Holders
Symbol
KAPA
CUSIP
48301N104
Type
Equity
Class
COM
Num filings
6
Total reported value, excl. options
$618 k
Compare 2024 Q4 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type